Since the introduction of ICH-E6 R2 Addendum sponsors must introduce formal Quality Risk Management and define Quality Tolerance Limits to their clinical development programs. 

This webinar will cover an introduction to those concepts, recent developments and examples of how companies are defining QTLs in practice 

There will also be the opportunity to have a panel discussion with the presenters:  Tim Rolfe (GSK), Marcin Macowski (GSK), Marta Kozinska (AZ) and Chris Wells (Roche).